Cambridge University Press
  • Welcome Guest user
  • Log in | Register
 
Athens log in
Username Password  
Forgot your password?
Subscribe now to view full content , or if you already have an account,
please Login to access this feature
Subscribe now to view full content, or if you already have an account,
please Login to access this feature
Subscribe now to access this feature, or if you already have an account,
please Login.
 
 
  • Advanced search
Cambridge University Press logo
Stahl's Essential Psychopharmacology Online
In Collaboration With NEI
Stahl's Essential Psychopharmacology

Navigation

  • Home
  • The
    Prescriber's Guide
  • Essential
    Psychopharmacology
  • Essential
    Neuropharmacology
  • Other
    Resources
    • Next Generation Antidepressants:
      Beyer and Stahl
  • Stahl's
    Illustrated
  • Drug
    Interaction
 
  • My Bookmarks
  • TOC
  • Bromocriptine
  • Therapeutics
  • Side Effects
  • Dosing and Use
  • Special Populations
  • Art of Psychopharmacology
  • Suggested Reading

Bromocriptine

Therapeutics

Brands

• Parlodel, Serocryptin

Generic?

Yes

Class

• Dopamine agonist, ergot

Commonly Prescribed for

(FDA approved in bold)
• Parkinson's disease (PD)
• Acromegaly
• Hyperprolactinemia

How the drug works

• Dopamine agonist, with high affinity for the D2 receptor. This action is the reason for effectiveness. Also has weak alpha-agonist activity. In the treatment of hormone-secreting pituitary adenomas, bromocriptine works as a dopamine agonist, which inhibits prolactin-secreting cells in the anterior pituitary, reducing tumor size

How Long Until It Works

• PD - weeks

If It Works

• PD - may require dose adjustments over time or augmentation with other agents. Most PD patients will eventually require levodopa-carbidopa to manage their symptoms

If It Doesn't Work

• PD - Bradykinesia, gait and tremor should improve. Non-motor symptoms including autonomic symptoms such as postural hypotension, depression, and bladder dysfunction do not improve. If the patient has significantly impaired functioning, add or replace with levodopa

Best Augmenting Combos for Partial Response or Treatment-Resistance

• For suboptimal effectiveness add carbidopa-levodopa with or without a COMT inhibitor. MAO-B may also be beneficial
• For younger patients with bothersome tremor: anticholinergics may help
• For severe motor fluctuations and/or dyskinesias with good “on” time, functional neurosurgery (deep brain stimulation) is an option
• Depression is common in PD and may respond to low dose SSRIs
• Cognitive impairment/dementia is common in mid-late stage PD and may improve with acetylcholinesterase inhibitors
• For patients with late-stage PD experiencing hallucinations or delusions, withdraw bromocriptine and consider oral atypical neuroleptics (quetiapine, olanzapine, clozapine). Acute psychosis is a medical emergency that may require hospitalization for stabilization

Tests

• None required
 

Current Prices for Individual Subscribers (prices are subject to change)

  Pay-per-view Subscription (48 hours) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447990


$ 40
  Annual Subscription (Single User) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447983


$ 195
  Print + Online Access (One Year, Single User) Unit price

Purchase

Stahl's Essential Psychopharmacology Online

Digital Edition: Print and Online

Once you are sent the Digital Edition, just enter the code from the inside back cover to activate your one-year access to www.stahlonline.org.

ISBN: 9780521746090


$261
For pricing and information for Academic and Medical Libraries, Corporate, Nonprofit or Government Institutions and/or special sales or website sponsorship,

for the Americas please contact:
Cambridge Library Sales,
stahlonline@cambridge.org,
800-221-4512, x6535.

For the rest of the world, please contact:
academicsales@cambridge.org
or call +44 (0) 1223 325741.

Australia and New Zealand
Phone: +61 (3) 8671 1400,
Fax: +61 3 9676 9966,
Email: enquiries@cambridge.edu.au.

 

Footer links

  • About Cambridge University Press
  • About NEI
  • About Dr. Stahl
  • About the Illustrator
  • © Cambridge University Press 2008.
  • Copyright statement
  • Privacy Policy
  • Accessibility
  • Terms of use
  • FAQ
  • Help
  • View Access Details
  • Contact us